Approvals/TGA/SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack

Approved

STANDARD

SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3221691cc2e7d645
Product Name: SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack
Artg Id: 53775
Artg Name: SEREVENT ACCUHALER salmeterol 50 micrograms (as xinafoate) powder for inhalation blister pack
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 1995-10-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2d9daea1801d15e23b7496dc1d3be284.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f6b06026e2ed4e432de481979111808b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

3221691cc2e7d645

Type

Standard